These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34540833)

  • 1. Developing Cytokine Storm-Sensitive Therapeutic Strategy in COVID-19 Using 8P9R Chimeric Peptide and Soluble ACE2.
    Nazerian Y; Vakili K; Ebrahimi A; Niknejad H
    Front Cell Dev Biol; 2021; 9():717587. PubMed ID: 34540833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation.
    Wallentin L; Lindbäck J; Eriksson N; Hijazi Z; Eikelboom JW; Ezekowitz MD; Granger CB; Lopes RD; Yusuf S; Oldgren J; Siegbahn A
    Eur Heart J; 2020 Nov; 41(41):4037-4046. PubMed ID: 32984892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble angiotensin-converting enzyme 2 is transiently elevated in COVID-19 and correlates with specific inflammatory and endothelial markers.
    Lundström A; Ziegler L; Havervall S; Rudberg AS; von Meijenfeldt F; Lisman T; Mackman N; Sandén P; Thålin C
    J Med Virol; 2021 Oct; 93(10):5908-5916. PubMed ID: 34138483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2/ACE2 Interaction Suppresses IRAK-M Expression and Promotes Pro-Inflammatory Cytokine Production in Macrophages.
    Pantazi I; Al-Qahtani AA; Alhamlan FS; Alothaid H; Matou-Nasri S; Sourvinos G; Vergadi E; Tsatsanis C
    Front Immunol; 2021; 12():683800. PubMed ID: 34248968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concentrations of Soluble Angiotensin Converting Enzyme 2 (sACE2) in Children and Adults with and without COVID-19.
    Wissing SI; Obeid R; Rädle-Hurst T; Rohrer T; Herr C; Schöpe J; Geisel J; Bals R; Abdul-Khaliq H
    J Clin Med; 2022 Nov; 11(22):. PubMed ID: 36431276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex difference in circulating soluble form of ACE2 protein in moderate and severe COVID-19 and healthy controls.
    Robertson J; Nellgård B; Hultén LM; Nilsson S; Dalla K; Börjesson M; Zetterberg H; Svanvik J; Gisslén M
    Front Med (Lausanne); 2022; 9():1058120. PubMed ID: 36569121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients.
    Osman IO; Melenotte C; Brouqui P; Million M; Lagier JC; Parola P; Stein A; La Scola B; Meddeb L; Mege JL; Raoult D; Devaux CA
    Front Immunol; 2021; 12():625732. PubMed ID: 34194422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 cytokine storm: The anger of inflammation.
    Mahmudpour M; Roozbeh J; Keshavarz M; Farrokhi S; Nabipour I
    Cytokine; 2020 Sep; 133():155151. PubMed ID: 32544563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An immunotherapeutic method for COVID-19 patients: a soluble ACE2-Anti-CD16 VHH to block SARS-CoV-2 Spike protein.
    Sheikhi A; Hojjat-Farsangi M
    Hum Vaccin Immunother; 2021 Jan; 17(1):92-97. PubMed ID: 32663051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
    J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D.
    Peng MY; Liu WC; Zheng JQ; Lu CL; Hou YC; Zheng CM; Song JY; Lu KC; Chao YC
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19: Zinc and Angiotensin-Converting Enzyme 2 (ACE2) Deficiencies as Determinants of Risk and Severity of Disease: A Narrative Review.
    Salgo MP
    Infect Dis Ther; 2021 Sep; 10(3):1215-1225. PubMed ID: 34251655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating Soluble ACE2 and Upstream microRNA Expressions in Serum of Type 2 Diabetes Mellitus Patients.
    Elemam NM; Hasswan H; Aljaibeji H; Sulaiman N
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34067683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of cytokine storm and systemic inflammation on liver impairment patients infected by SARS-CoV-2: Prospective therapeutic challenges.
    Ali FEM; Mohammedsaleh ZM; Ali MM; Ghogar OM
    World J Gastroenterol; 2021 Apr; 27(15):1531-1552. PubMed ID: 33958841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calming the Storm: Natural Immunosuppressants as Adjuvants to Target the Cytokine Storm in COVID-19.
    Peter AE; Sandeep BV; Rao BG; Kalpana VL
    Front Pharmacol; 2020; 11():583777. PubMed ID: 33708109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profiling Levels of Serum microRNAs and Soluble ACE2 in COVID-19 Patients.
    Elemam NM; Hasswan H; Aljaibeji H; Sharif-Askari NS; Halwani R; Taneera J; Sulaiman N
    Life (Basel); 2022 Apr; 12(4):. PubMed ID: 35455065
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative docking studies to understand the binding affinity of nicotine with soluble ACE2 (sACE2)-SARS-CoV-2 complex over sACE2.
    C SK; Kumar SA; Wei H
    Toxicol Rep; 2020; 7():1366-1372. PubMed ID: 33052306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives.
    Saponaro F; Rutigliano G; Sestito S; Bandini L; Storti B; Bizzarri R; Zucchi R
    Front Mol Biosci; 2020; 7():588618. PubMed ID: 33195436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 as a viral functional ACE2 deficiency disorder with ACE2 related multi-organ disease.
    Gan R; Rosoman NP; Henshaw DJE; Noble EP; Georgius P; Sommerfeld N
    Med Hypotheses; 2020 Nov; 144():110024. PubMed ID: 32758871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble Angiotensin Converting Enzyme 2 (ACE2) Is Upregulated and Soluble Endothelial Nitric Oxide Synthase (eNOS) Is Downregulated in COVID-19-induced Acute Respiratory Distress Syndrome (ARDS).
    Vassiliou AG; Zacharis A; Keskinidou C; Jahaj E; Pratikaki M; Gallos P; Dimopoulou I; Kotanidou A; Orfanos SE
    Pharmaceuticals (Basel); 2021 Jul; 14(7):. PubMed ID: 34358119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.